Teligent Current Ratio 2006-2018 | TLGT

Teligent current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Teligent Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.05B $0.04B 1.32
2018-06-30 $0.05B $0.02B 2.75
2018-03-31 $0.05B $0.02B 2.73
2017-12-31 $0.06B $0.02B 3.16
2017-09-30 $0.08B $0.03B 3.16
2017-06-30 $0.10B $0.02B 4.37
2017-03-31 $0.10B $0.02B 5.62
2016-12-31 $0.10B $0.02B 6.90
2016-09-30 $0.11B $0.01B 8.48
2016-06-30 $0.11B $0.01B 8.60
2016-03-31 $0.12B $0.01B 9.08
2015-12-31 $0.12B $0.01B 10.85
2015-09-30 $0.16B $0.01B 17.78
2015-06-30 $0.17B $0.01B 13.11
2015-03-31 $0.18B $0.02B 11.66
2014-12-31 $0.18B $0.01B 13.63
2014-09-30 $0.03B $0.01B 2.90
2014-06-30 $0.01B $0.01B 2.28
2014-03-31 $0.01B $0.00B 2.66
2013-12-31 $0.01B $0.01B 2.02
2013-09-30 $0.01B $0.00B 2.50
2013-06-30 $0.01B $0.00B 2.31
2013-03-31 $0.01B $0.00B 2.52
2012-12-31 $0.01B $0.00B 3.11
2012-09-30 $0.00B $0.00B 3.16
2012-06-30 $0.01B $0.00B 3.17
2012-03-31 $0.01B $0.00B 3.22
2011-12-31 $0.01B $0.00B 4.32
2011-09-30 $0.01B $0.00B 6.05
2011-06-30 $0.01B $0.00B 7.08
2011-03-31 $0.01B $0.00B 6.90
2010-12-31 $0.01B $0.00B 7.91
2010-09-30 $0.00B $0.00B 1.97
2010-06-30 $0.00B $0.00B 2.25
2010-03-31 $0.00B $0.00B 2.67
2009-12-31 $0.00B $0.00B 2.74
2009-09-30 $0.00B $0.00B 3.38
2009-06-30 $0.01B $0.00B 3.56
2009-03-31 $0.01B $0.01B 1.05
2008-12-31 $0.00B $0.00B 0.96
2008-09-30 $0.00B $0.00B 1.24
2008-06-30 $0.00B $0.00B 1.62
2008-03-31 $0.00B $0.00B 2.08
2007-12-31 $0.00B $0.00B 1.69
2007-09-30 $0.00B $0.00B 0.92
2007-06-30 $0.00B $0.00B 0.91
2007-03-31 $0.00B $0.00B 0.98
2006-12-31 $0.00B $0.00B 0.64
2006-09-30 $0.00B $0.00B 0.65
2006-06-30 $0.00B $0.00B 0.58
2006-03-31 $0.00B $0.00B 0.64
2005-12-31 $0.00B $0.00B 0.70
2005-09-30 $0.00B $0.00B 1.46
2005-06-30 $0.00B $0.00B 1.89
2005-03-31 $0.00B $0.00B 1.96
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.087B $0.067B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Bausch Health Cos (BHC) Canada $8.901B 6.44
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.817B 3.03
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.017B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00